PLA2G7 and atherosclerosis: Furthermore, subjects with the loss‐of‐function mutation (V279F) possibly suffer from greater incidence and severity of cardiovascular conditions compared with noncarriers.11 However, other lines of evidence suggest that Lp‐PLA2 contributes to the development and progression of atherosclerosis.